Literature DB >> 21875542

The TEN study: time epinephrine needs to reach muscle.

Troy W Baker1, Christopher M Webber, Adrienne Stolfi, Erika Gonzalez-Reyes.   

Abstract

BACKGROUND: An epinephrine autoinjector (EAI) is designed to deliver epinephrine into the vastus lateralis muscle. Several studies have demonstrated both patient and physician difficulties in correctly using EAIs, specifically premature removal of the device from the thigh.
OBJECTIVE: To evaluate the correlation between duration of injection with an EAI and amount of epinephrine absorbed into muscle tissue.
METHODS: Twenty-one EAI devices (0.3 mL) were used to determine the amount of epinephrine injected into marbleized beef during 7 time periods. A digital scale was used to record preinjection and postinjection weights of EAIs and beef. The weight difference between the preinjection and postinjection periods of the EAIs was used to calculate the total amount of epinephrine released and available for absorption into the marbleized beef. The difference between the preinjection and postinjection beef weight was used to determine the amount of epinephrine absorbed into the meat.
RESULTS: The correlation with duration of injection for both the amount of epinephrine absorbed and released was 0.321 (P = .48). At all intervals, 95.9% or more of epinephrine was absorbed into the marbleized beef. The correlation with duration of injection and percent of epinephrine absorbed was 0.464 (P = .29). There were no time periods that were significantly different from the percentage of epinephrine absorbed by the marbleized beef at 10 seconds (analysis of variance P = .16).
CONCLUSION: No linear relationship between time and amount of epinephrine injected or absorbed into muscle tissue was demonstrated. These data suggest that holding the device in place for 1 second is as effective as 10 seconds.
Copyright © 2011 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21875542     DOI: 10.1016/j.anai.2011.06.001

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  5 in total

1.  Epinephrine for Anaphylaxis; Are You Ready to Treat Anaphylaxis?; Don't Open Pradaxa Capsules; Control New Ropivacaine Minibags.

Authors:  Michael R Cohen; Judy L Smetzer
Journal:  Hosp Pharm       Date:  2015-06

2.  EPINEPHrine for Anaphylaxis: Autoinjector or 1-mg Vial or Ampoule?

Authors:  Matthew Grissinger
Journal:  P T       Date:  2017-12

3.  Usability of a new disposable autoinjector platform device: results of a formative study conducted with a broad user population.

Authors:  Jakob Lange; Philipp Richard; Nick Bradley
Journal:  Med Devices (Auckl)       Date:  2015-06-03

Review 4.  Update on the usage and safety of epinephrine auto-injectors, 2017.

Authors:  Larry S Posner; Carlos A Camargo
Journal:  Drug Healthc Patient Saf       Date:  2017-03-21

5.  Hooked epinephrine auto-injector devices in children: four case reports with three different proposed mechanisms.

Authors:  Ran D Goldman; Katharine C Long; Julie C Brown
Journal:  Allergy Asthma Clin Immunol       Date:  2020-03-14       Impact factor: 3.406

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.